Elevance Health
1,659 hedge funds and large institutions have $98.5B invested in Elevance Health in 2023 Q4 according to their latest regulatory filings, with 234 funds opening new positions, 595 increasing their positions, 594 reducing their positions, and 88 closing their positions.
166% more first-time investments, than exits
New positions opened: 234 | Existing positions closed: 88
14% more capital inflows, than outflows
Capital inflows: $5.02B | Capital outflows: $4.41B
10% more call options, than puts
Call options by funds: $821M | Put options by funds: $744M
9% more funds holding
Funds holding: 1,526 → 1,659 (+133)
0.69% more ownership
Funds ownership: 88.18% → 88.87% (+0.69%)
0% more repeat investments, than reductions
Existing positions increased: 595 | Existing positions reduced: 594
11% less funds holding in top 10
Funds holding in top 10: 55 → 49 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$458M |
| 2 |
Man Group
London,
United Kingdom
|
+$292M |
| 3 |
BlackRock
New York
|
+$248M |
| 4 |
Morningstar Investment Services
Chicago,
Illinois
|
+$236M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$193M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Putnam Investments
Boston,
Massachusetts
|
-$387M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$316M |
| 3 |
Two Sigma Advisers
New York
|
-$230M |
| 4 |
Farallon Capital Management
San Francisco,
California
|
-$166M |
| 5 |
Two Sigma Investments
New York
|
-$164M |
ELV Hedge Fund Activity: Q4 2023 in Review
1,659 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Elevance Health (ELV) for Q4 2023, worth a combined $98.5B — up 8.4% from $90.9B a quarter earlier.
Buyers outnumbered sellers: 234 funds opened new ELV positions and 88 closed out — a net gain of 146 holders — while 595 added to existing stakes and 594 trimmed.
The largest buyer was Massachusetts Financial Services, opening a new position worth an estimated $458M. The largest seller was Putnam Investments, cutting an estimated $387M.
- 1,659 institutional investors held Elevance Health (ELV) as of Q4 2023, up from 1,526 in Q3 2023.
- Funds reported $98.5B of Elevance Health stock for Q4 2023, up 8.4% quarter-over-quarter.
- 234 funds opened new Elevance Health positions in Q4 2023 and 88 closed out, a net change of +146 holders.
- The largest Elevance Health buyer in Q4 2023 was Massachusetts Financial Services, an estimated $458M added.
- The largest Elevance Health seller in Q4 2023 was Putnam Investments, an estimated $387M sold.
Based on aggregated 13F filings for Q4 2023.